Genetic variation in APOE cluster region and Alzheimer's disease risk

Neurobiology of Aging

Volumn 32, Issue 11, 2011, Pages 2107.e7-2107.e17

  Cervantes, Sebastián ^a,b   Samaranch, Lluís ^a   Vidal Taboada, José Manuel ^a   Lamet, Isabel ^b   Bullido, María Jesús ^c,d   Frank García, Ana ^d,e   Coria, Francisco ^f   Lleó, Albert ^d,g   Clarimón, Jordi ^d,g   Lorenzo, Elena ^a   Alonso, Elena ^a   Sánchez Juan, Pascual ^d,h   Rodríguez Rodríguez, Eloy ^d,h   Combarros, Onofre ^d,h   Rosich, Marcel ⁱ   Vilella, Elisabet ⁱ   Pastor, Pau ^a,b,d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^f HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁱ IISPV   (Spain)

Author keywords

Alzheimer's disease; APOC1; APOC2; APOC4; APOE; Genetics; Mapping; Mild cognitive impairment; TOMM40

Indexed keywords

ALZHEIMER DISEASE; APOC1 GENE; APOC2 GENE; APOC4 GENE; APOE EPSILON4 GENE; APOE GENE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; FEMALE; GENE; GENE CLUSTER; GENE IDENTIFICATION; GENE MAPPING; GENE REGULATORY NETWORK; GENE SEQUENCE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TOMM40 GENE;

EID: 80052631417     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.05.023     Document Type: Article

References (61)

1. Abhary S., Burdon K.P., Kuot A., Javadiyan S., Whiting M.J., Kasmeridis N., Petrovsky N., Craig J.E. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes. PLoS One 2010, 5:e9462.
2. Abraham R., Moskvina V., Sims R., Hollingworth P., Morgan A., Georgieva L., Dowzell K., Cichon S., Hillmer A.M., O'Donovan M.C., Williams J., Owen M.J., Kirov G. A genome-wide association study for late-onset Alzheimer's disease using DNA pooling. BMC Med. Genomics 2008, 1:44.
3. Allan C.M., Walker D., Segrest J.P., Taylor J.M. Identification and characterization of a new human gene (APOC4) in the apolipoprotein E, C-I, and C-II gene locus. Genomics 1995, 28:291-300.
4. 2010 Alzheimer's disease facts and figures. Alzheimers Dement 2010, 6:158-194. Alzheimer's Association.
5. Anandatheerthavarada H.K., Biswas G., Robin M.A., Avadhani N.G. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol 2003, 161:41-54.
6. Ariza M.J., Sánchez-Chaparro M.A., Barón F.J., Hornos A.M., Calvo-Bonacho E., Rioja J., Valdivielso P., Gelpi J.A., González-Santos P. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the Icaria genetic sub-study. BMC Med. Genet 2010, 11:66.
7. Artiga M.J., Bullido M.J., Sastre I., Recuero M., García M.A., Aldudo J., Vázquez J., Valdivieso F. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett 1998, 421:105-108.
8. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
9. Bekris L.M., Millard S.P., Galloway N.M., Vuletic S., Albers J.J., Li G., Galasko D.R., DeCarli C., Farlow M.R., Clark C.M., Quinn J.F., Kaye J.A., Schellenberg G.D., Tsuang D., Peskind E.R., Yu C.E. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J. Alzheimers Dis 2008, 13:255-266.
10. Belbin O., Dunn J.L., Ling Y., Morgan L., Chappell S., Beaumont H., Warden D., Smith D.A., Kalsheker N., Morgan K. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease. Hum. Mol. Genet 2007, 16:2199-2208.
11. Bertram L., Lange C., Mullin K., Parkinson M., Hsiao M., Hogan M.F., Schjeide B.M., Hooli B., Divito J., Ionita I., Jiang H., Laird N., Moscarillo T., Ohlsen K.L., Elliott K., Wang X., Hu-Lince D., Ryder M., Murphy A., Wagner S.L., Blacker D., Becker K.D., Tanzi R.E. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am. J. Hum. Genet 2008, 83:623-632.
12. Blom E.S., Holmans P., Arepalli S., Adighibe O., Hamshere M.L., Gatz M., Pedersen N.L., Bergem A.L., Owen M.J., Hollingworth P., Goate A., Williams J., Lannfelt L., Hardy J., Wavrant-De Vrièze F., Glaser A. Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13?. Am. J. Med. Genet. B Neuropsychiatr. Genet 2008, 147B:778-783.
13. Bullido M.J., Artiga M.J., Recuero M., Sastre I., García M.A., Aldudo J., Lendon C., Han S.W., Morris J.C., Frank A., Vázquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet 1998, 18:69-71.
14. Bullido M.J., Valdivieso F. Apolipoprotein E gene promoter polymorphisms in Alzheimer's disease. Microsc. Res. Tech 2000, 50:261-267.
15. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M., Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942.
16. Chartier-Harlin M.C., Parfitt M., Legrain S., Pérez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V., et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q132 chromosomal region. Hum. Mol. Genet 1994, 3:569-574.
17. Coon K.D., Myers A.J., Craig D.W., Webster J.A., Pearson J.V., Lince D.H., Zismann V.L., Beach T.G., Leung D., Bryden L., Halperin R.F., Marlowe L., Kaleem M., Walker D.G., Ravid R., Heward C.B., Rogers J., Papassotiropoulos A., Reiman E.M., Hardy J., Stephan D.A. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J. Clin. Psychiatry 2007, 68:613-618.
18. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
19. Coria F., Rubio I., Bayón C., Cuadrado N., Santa-Engracia N., Rodríguez-Artalejo F. Apolipoprotein E allelic variants predict dementia in elderly patients with memory impairment. Eur. J. Neurol 1995, 2:191-193.
20. Crean S., Ward A., Mercaldi C.J., Collins J.M., Cook M.N., Baker N.L., Arrighi H.M. Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis. Dement. Geriatr. Cogn. Disord 2011, 31:20-30.
21. Cruchaga C., Fernández-Seara M.A., Seijo-Martínez M., Samaranch L., Lorenzo E., Hinrichs A., Irigoyen J., Maestro C., Prieto E., Martí-Climent J.M., Arbizu J., Pastor M.A., Pastor P. Cortical atrophy and language network reorganization associated with a novel progranulin mutation. Cereb. Cortex 2009, 19:1751-1760.
22. Del Greco M.F., Pattaro C., Luchner A., Pichler I., Winkler T., Hicks A.A., Fuchsberger C., Franke A., Melville S.A., Peters A., Wichmann H.E., Schreiber S., Heid I.M., Krawczak M., Minelli C., Wiedermann C.J., Pramstaller P.P. Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster. Hum. Mol. Genet 2011, 20:1660-1671.
23. Desmet F.O., Hamroun D., Lalande M., Collod-Béroud G., Claustres M., Béroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009, 37:e67.
24. Drigalenko E., Poduslo S., Elston R. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease. Neurology 1998, 51:131-135.
25. Ezquerra M., Lleó A., Castellví M., Queralt R., Santacruz P., Pastor P., Molinuevo J.L., Blesa R., Oliva R. A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease. Arch. Neurol 2003, 60:1149-1151.
26. Gabriel K., Egan B., Lithgow T. Tom40, the import channel of the mitochondrial outer membrane, plays an active role in sorting imported proteins. EMBO J 2003, 22:2380-2386.
27. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
28. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 2006, 63:168-174.
29. Goate A., Chartier-Harlin M.C., Mullan M., Brown J., Crawford F., Fidani L., Giuffra L., Haynes A., Irving N., James L., et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991, 349:704-706.
30. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schurmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Hull M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet 2009, 41:1088-1093.
31. Hong M.G., Alexeyenko A., Lambert J.C., Amouyel P., Prince J.A. Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease. J. Hum. Genet 2010, 55:707-709.
32. Lambert J.C., Araria-Goumidi L., Myllykangas L., Ellis C., Wang J.C., Bullido M.J., Harris J.M., Artiga M.J., Hernandez D., Kwon J.M., Frigard B., Petersen R.C., Cumming A.M., Pasquier F., Sastre I., Tienari P.J., Frank A., Sulkava R., Morris J.C., St Clair D., Mann D.M., Wavrant-DeVrièze F., Ezquerra-Trabalon M., Amouyel P., Hardy J., Haltia M., Valdivieso F., Goate A.M., Pérez-Tur J., Lendon C.L., Chartier-Harlin M.C. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology 2002, 59:59-66.
33. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fiévet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossu P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanché H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alperovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet 2009, 41:1094-1099. European Alzheimer's Disease Initiative Investigators.
34. Lambert J.C., Pérez-Tur J., Dupire M.J., Galasko D., Mann D., Amouyel P., Hardy J., Delacourte A., Chartier-Harlin M.C. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum. Mol. Genet 1997, 6:2151-2154.
35. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K., et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995, 269:973-977.
36. Li H., Wetten S., Li L., St Jean P.L., Upmanyu R., Surh L., Hosford D., Barnes M.R., Briley J.D., Borrie M., Coletta N., Delisle R., Dhalla D., Ehm M.G., Feldman H.H., Fornazzari L., Gauthier S., Goodgame N., Guzman D., Hammond S., Hollingworth P., Hsiung G.Y., Johnson J., Kelly D.D., Keren R., Kertesz A., King K.S., Lovestone S., Loy-English I., Matthews P.M., Owen M.J., Plumpton M., Pryse-Phillips W., Prinjha R.K., Richardson J.C., Saunders A., Slater A.J., St George-Hyslop P.H., Stinnett S.W., Swartz J.E., Taylor R.L., Wherrett J., Williams J., Yarnall D.P., Gibson R.A., Irizarry M.C., Middleton L.T., Roses A.D. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch. Neurol 2008, 65:45-53.
37. Lleó A., Blesa R., Gendre J., Castellví M., Pastor P., Queralt R., Oliva R. A novel presenilin 2 gene mutation (D439A) in a patient with early-onset Alzheimer's disease. Neurology 2001, 57:1926-1928.
38. Lutz M.W., Crenshaw D.G., Saunders A.M., Roses A.D. Genetic variation at a single locus and age of onset for Alzheimer's disease. Alzheimers Dement 2010, 6:125-131.
39. Manso H., Krug T., Sobral J., Albergaria I., Gaspar G., Ferro J.M., Oliveira S.A., Vicente A.M. Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med. Genet 2010, 11:40.
40. Morris J.C., Roe C.M., Xiong C., Fagan A.M., Goate A.M., Holtzman D.M., Mintun M.A. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann. Neurol 2010, 67:122-131.
41. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet 2004, 74:765-769.
42. Orozco G., Hinks A., Eyre S., Ke X., Gibbons L.J., Bowes J., Flynn E., Martin P., Wilson A.G., Bax D.E., Morgan A.W., Emery P., Steer S., Hocking L., Reid D.M., Wordsworth P., Harrison P., Thomson W., Barton A., Worthington J. Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23. Hum. Mol. Genet 2009, 18:2693-2699. Wellcome Trust Case Control Consortium; YEAR consortium.
43. Pastor P., Roe C.M., Villegas A., Bedoya G., Chakraverty S., García G., Tirado V., Norton J., Ríos S., Martínez M., Kosik K.S., Lopera F., Goate A.M. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred. Ann. Neurol 2003, 54:163-169.
44. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild Cognitive impairment: clinical characterization and outcome. Arch. Neurol 1999, 56:303-308.
45. Petersen R.C., Roberts R.O., Knopman D.S., Boeve B.F., Geda Y.E., Ivnik R.J., Smith G.E., Jack C.R. Mild cognitive impairment: ten years later. Arch. Neurol 2009, 66:1447-1455.
46. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet 2007, 81:559-575.
47. Quandt K., Frech K., Karas H., Wingender E., Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995, 23:4878-4884.
48. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995, 376:775-778.
49. Roses A.D., Lutz M.W., Amrine-Madsen H., Saunders A.M., Crenshaw D.G., Sundseth S.S., Huentelman M.J., Welsh-Bohmer K.A., Reiman E.M. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J 2010, 10:375-384.
50. Samaranch L., Cervantes S., Barabash A., Alonso A., Cabranes J.A., Lamet I., Ancín I., Lorenzo E., Martínez-Lage P., Marcos A., Clarimón J., Alcolea D., Lleó A., Blesa R., Gómez-Isla T., Pastor P. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia. J. Alzheimers Dis 2010, 22:1065-1071.
51. Schulze T.G., Detera-Wadleigh S.D., Akula N., Gupta A., Kassem L., Steele J., Pearl J., Strohmaier J., Breuer R., Schwarz M., Propping P., Nöthen M.M., Cichon S., Schumacher J., Rietschel M., McMahon F.J. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol. Psychiatry 2009, 14:487-491. NIMH Genetics Initiative Bipolar Disorder Consortium.
52. Seshadri S., Fitzpatrick A.L., Ikram M.A., DeStefano A.L., Gudnason V., Boada M., Bis J.C., Smith A.V., Carassquillo M.M., Lambert J.C., Harold D., Schrijvers E.M., Ramirez-Lorca R., Debette S., Longstreth W.T., Janssens A.C., Pankratz V.S., Dartigues J.F., Hollingworth P., Aspelund T., Hernandez I., Beiser A., Kuller L.H., Koudstaal P.J., Dickson D.W., Tzourio C., Abraham R., Antunez C., Du Y., Rotter J.I., Aulchenko Y.S., Harris T.B., Petersen R.C., Berr C., Owen M.J., Lopez-Arrieta J., Varadarajan B.N., Becker J.T., Rivadeneira F., Nalls M.A., Graff-Radford N.R., Campion D., Auerbach S., Rice K., Hofman A., Jonsson P.V., Schmidt H., Lathrop M., Mosley T.H., Au R., Psaty B.M., Uitterlinden A.G., Farrer L.A., Lumley T., Ruiz A., Williams J., Amouyel P., Younkin S.G., Wolf P.A., Launer L.J., Lopez O.L., van Duijn C.M., Breteler M.M. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 2010, 303:1832-1840. CHARGE Consortium, GERAD1 Consortium, EADI1 Consortium.
53. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sanseau P., Polinsky R.J., Wasco W., Da Silva H.A., Haines J.L., Perkicak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., St George-Hyslop P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995, 375:754-760.
54. Shin E.K., Lee S.H., Cho S.H., Jung S., Yoon S.H., Park S.W., Park J.S., Uh S.T., Kim Y.K., Kim Y.H., Choi J.S., Park B.L., Shin H.D., Park C.S. Association between colony-stimulating factor 1 receptor gene polymorphisms and asthma risk. Hum. Genet 2010, 128:293-302.
55. Singh P.P., Singh M., Mastana S.S. APOE distribution in world populations with new data from India and the UK. Ann. Hum. Biol 2006, 33:279-308.
56. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:1977-1981.
57. Sun Y., Shi J., Zhang S., Tang M., Han H., Guo Y., Ma C., Liu X., Li T. The APOC3 SstI polymorphism is weakly associated with sporadic Alzheimer's disease in a Chinese population. Neurosci. Lett 2005, 380:219-222.
58. Takei N., Miyashita A., Tsukie T., Arai H., Asada T., Imagawa M., Shoji M., Higuchi S., Urakami K., Kimura H., Kakita A., Takahashi H., Tsuji S., Kanazawa I., Ihara Y., Odani S., Kuwano R. Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. Genomics 2009, 93:441-448. Japanese Genetic Study Consortium for Alzheimer Disease.
59. Wei C.F., Tsao Y.K., Robberson D.L., Gotto A.M., Brown K., Chan L. The structure of the human apolipoprotein C-II gene. Electron microscopic analysis of RNA:DNA hybrids, complete nucleotide sequence, and identification of 5' homologous sequences among apolipoprotein genesJ. Biol. Chem 1985, 260:15211-15221.
60. Xin X.Y., Ding J.Q., Chen S.D. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis. J. Alzheimers Dis 2010, 19:1283-1294.
61. Yu C.E., Seltman H., Peskind E.R., Galloway N., Zhou P.X., Rosenthal E., Wijsman E.M., Tsuang D.W., Devlin B., Schellenberg G.D. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. Genomics 2007, 89:655-665.